PetMed Express, Inc. (PETS)
| Market Cap | 41.63M -37.4% |
| Revenue (ttm) | 179.02M -21.1% |
| Net Income | -57.29M |
| EPS | -2.74 |
| Shares Out | 21.03M |
| PE Ratio | n/a |
| Forward PE | 28.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 84,626 |
| Open | 1.970 |
| Previous Close | 1.970 |
| Day's Range | 1.965 - 2.000 |
| 52-Week Range | 1.570 - 4.100 |
| Beta | 0.79 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthri... [Read more]
Financial Performance
In fiscal year 2026, PetMed Express's revenue was $179.02 million, a decrease of -21.13% compared to the previous year's $226.97 million. Losses were -$57.29 million, 813.5% more than in 2025.
Financial StatementsNews
PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
DELRAY BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the first q...
PetMed Express enters $37M sale-leaseback transaction for headquarters
PetMed Express (PETS) announced that it has entered into a definitive agreement for a sale-leaseback transaction with an institutional real estate investor involving the company’s headquarters and dis...
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
DELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that it has entered into a definitive agreement ...
PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
DELRAY BEACH, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., doing business as PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that its new online pet pharmacy o...
PetMed Express confirms $3.00 per share acquisition proposal from SilverCape
PetMed Express (PETS) confirmed that its board of directors has received an unsolicited, non-binding, and conditional proposal from SilverCape Investments to acquire all outstanding shares of the comp...
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
DELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds” or the “Company”) (Nasdaq: PETS) today confirmed that its Board of Directors (the “Board”) has received an unsolic...
SilverCape revises proposal to acquire PetMed Express for $3.00 per share
SilverCape Investments released an open letter to the board of directors of PetMed Express (PETS) calling on the board to engage with SilverCape on a revised proposal to acquire all…
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
Unaccountable Board Led by Chair & Interim CEO Leslie C.G. Campbell Continues to Preside Over Stunning Destruction of Stockholder Value
PetMed Express Proxy statement: Proxy filing
PetMed Express filed a proxy statement on June 25, 2026, providing details for shareholder voting and corporate governance matters.
PetMed Express Proxy statement: Proxy filing
PetMed Express filed a proxy statement on June 25, 2026, providing details for shareholder voting and corporate governance matters.
PetMed Express to continue as public company after receipt of buyout offers
The company stated in its Q4 earnings announcement: “In December 2025, the Company received two unsolicited, non-binding preliminary proposals from two separate third parties to acquire all of the out...
PetMed Express reports Q4 EPS (19c) vs. (56c) last year
Reports Q4 revenue $42.82M vs. $50.76M last year. “We are pleased to report a modest sequential quarterly increase in fourth quarter net sales, demonstrating positive momentum as we close out…
PetMed Express Earnings Call Transcript: Q4 2026
Fiscal 2026 saw a 21.1% revenue decline and a $57.3M net loss, but operational improvements, cost reductions, and technology upgrades led to sequential Q4 sales growth and improved gross margin. The board rejected acquisition offers, focusing on long-term independence.
PetMed Express Earnings release: Q4 2026
PetMed Express released its Q4 2026 earnings on June 2, 2026, summarizing the period's financial results.
PetMed Express Annual report: Q4 2026
PetMed Express has published its Q4 2026 annual report on June 2, 2026.
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
DELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and f...
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth q...
PetMed Express partners with Rural King on pet pharmacy offering
PetMed Express (PETS) announced a strategic partnership with Rural King to launch a new pet pharmacy offering, expanding access to prescription medications, preventatives and pet health products for c...
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
Collaboration expands access to affordable pet medications for rural communities nationwide Collaboration expands access to affordable pet medications for rural communities nationwide
PetMed Express, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express , Inc. , (“ PetMed " or the "Company") ( NASDAQ : PETS) investors that the firm has initiated an investigat...
PetMed Express Quarterly report: Q3 2026
PetMed Express has published its Q3 2026 quarterly earnings report on February 4, 2026.
PetMed Express Quarterly report: Q2 2026
PetMed Express has published its Q2 2026 quarterly earnings report on December 19, 2025.
PetMed Express Quarterly report: Q1 2026
PetMed Express has published its Q1 2026 quarterly earnings report on December 19, 2025.
Cardone Ventures announces $4.25 per share proposal to acquire PetMed Express
Cardone Ventures submitted an unsolicited, non-binding proposal to acquire PetMed Express (PETS) for $4.25 per share in cash, representing an implied equity value of approximately $89M. The proposal w...
Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express
MIAMI--(BUSINESS WIRE)--Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-...